The underlying molecular mechanisms targeting the GABAergic system in the context of HD are still unknown, but evidence suggests that mHTT alters the transcription of genes and protein expression (e.g. GABAAR and KCC2) through interactions with transcriptional activators and repressors. Here, SLC12A5 is linked to Huntington disease.